List of Tables
Table 1. Hematologic Malignancies Detection Market Trends
Table 2. Hematologic Malignancies Detection Market Drivers & Opportunity
Table 3. Hematologic Malignancies Detection Market Challenges
Table 4. Hematologic Malignancies Detection Market Restraints
Table 5. Global Hematologic Malignancies Detection Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Hematologic Malignancies Detection Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Hematologic Malignancies Detection Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Hematologic Malignancies Detection Product Type
Table 9. Key Companies Time to Begin Mass Production of Hematologic Malignancies Detection
Table 10. Global Hematologic Malignancies Detection Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hematologic Malignancies Detection as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Hematologic Malignancies Detection Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Hematologic Malignancies Detection Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Hematologic Malignancies Detection Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Hematologic Malignancies Detection Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Hematologic Malignancies Detection Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Hematologic Malignancies Detection Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Hematologic Malignancies Detection Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Hematologic Malignancies Detection Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Hematologic Malignancies Detection Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Hematologic Malignancies Detection Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Hematologic Malignancies Detection Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Hematologic Malignancies Detection Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Hematologic Malignancies Detection Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Hematologic Malignancies Detection Sales Value by Region (2019-2024) & (%)
Table 27. Global Hematologic Malignancies Detection Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Hematologic Malignancies Detection Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Hematologic Malignancies Detection Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Hematologic Malignancies Detection Sales Value, (2025-2030) & (US$ Million)
Table 31. ArcherDx Basic Information List
Table 32. ArcherDx Description and Business Overview
Table 33. ArcherDx Hematologic Malignancies Detection Products, Services and Solutions
Table 34. Revenue (US$ Million) in Hematologic Malignancies Detection Business of ArcherDx (2019-2024)
Table 35. ArcherDx Recent Developments
Table 36. Bio-Rad Laboratories Basic Information List
Table 37. Bio-Rad Laboratories Description and Business Overview
Table 38. Bio-Rad Laboratories Hematologic Malignancies Detection Products, Services and Solutions
Table 39. Revenue (US$ Million) in Hematologic Malignancies Detection Business of Bio-Rad Laboratories (2019-2024)
Table 40. Bio-Rad Laboratories Recent Developments
Table 41. sysmex Basic Information List
Table 42. sysmex Description and Business Overview
Table 43. sysmex Hematologic Malignancies Detection Products, Services and Solutions
Table 44. Revenue (US$ Million) in Hematologic Malignancies Detection Business of sysmex (2019-2024)
Table 45. sysmex Recent Developments
Table 46. Invitae Basic Information List
Table 47. Invitae Description and Business Overview
Table 48. Invitae Hematologic Malignancies Detection Products, Services and Solutions
Table 49. Revenue (US$ Million) in Hematologic Malignancies Detection Business of Invitae (2019-2024)
Table 50. Invitae Recent Developments
Table 51. NeoGenomics Laboratories Basic Information List
Table 52. NeoGenomics Laboratories Description and Business Overview
Table 53. NeoGenomics Laboratories Hematologic Malignancies Detection Products, Services and Solutions
Table 54. Revenue (US$ Million) in Hematologic Malignancies Detection Business of NeoGenomics Laboratories (2019-2024)
Table 55. NeoGenomics Laboratories Recent Developments
Table 56. Abbott Laboratories Basic Information List
Table 57. Abbott Laboratories Description and Business Overview
Table 58. Abbott Laboratories Hematologic Malignancies Detection Products, Services and Solutions
Table 59. Revenue (US$ Million) in Hematologic Malignancies Detection Business of Abbott Laboratories (2019-2024)
Table 60. Abbott Laboratories Recent Developments
Table 61. Cancer Genetics Basic Information List
Table 62. Cancer Genetics Description and Business Overview
Table 63. Cancer Genetics Hematologic Malignancies Detection Products, Services and Solutions
Table 64. Revenue (US$ Million) in Hematologic Malignancies Detection Business of Cancer Genetics (2019-2024)
Table 65. Cancer Genetics Recent Developments
Table 66. Adaptive Biotechnologies Corporation Basic Information List
Table 67. Adaptive Biotechnologies Corporation Description and Business Overview
Table 68. Adaptive Biotechnologies Corporation Hematologic Malignancies Detection Products, Services and Solutions
Table 69. Revenue (US$ Million) in Hematologic Malignancies Detection Business of Adaptive Biotechnologies Corporation (2019-2024)
Table 70. Adaptive Biotechnologies Corporation Recent Developments
Table 71. Asuragen Basic Information List
Table 72. Asuragen Description and Business Overview
Table 73. Asuragen Hematologic Malignancies Detection Products, Services and Solutions
Table 74. Revenue (US$ Million) in Hematologic Malignancies Detection Business of Asuragen (2019-2024)
Table 75. Asuragen Recent Developments
Table 76. Invivoscribe Basic Information List
Table 77. Invivoscribe Description and Business Overview
Table 78. Invivoscribe Hematologic Malignancies Detection Products, Services and Solutions
Table 79. Revenue (US$ Million) in Hematologic Malignancies Detection Business of Invivoscribe (2019-2024)
Table 80. Invivoscribe Recent Developments
Table 81. Nanjing Shihejiyin Technology Basic Information List
Table 82. Nanjing Shihejiyin Technology Description and Business Overview
Table 83. Nanjing Shihejiyin Technology Hematologic Malignancies Detection Products, Services and Solutions
Table 84. Revenue (US$ Million) in Hematologic Malignancies Detection Business of Nanjing Shihejiyin Technology (2019-2024)
Table 85. Nanjing Shihejiyin Technology Recent Developments
Table 86. Annaroad Gene Technology Basic Information List
Table 87. Annaroad Gene Technology Description and Business Overview
Table 88. Annaroad Gene Technology Hematologic Malignancies Detection Products, Services and Solutions
Table 89. Revenue (US$ Million) in Hematologic Malignancies Detection Business of Annaroad Gene Technology (2019-2024)
Table 90. Annaroad Gene Technology Recent Developments
Table 91. BGI Genomics Basic Information List
Table 92. BGI Genomics Description and Business Overview
Table 93. BGI Genomics Hematologic Malignancies Detection Products, Services and Solutions
Table 94. Revenue (US$ Million) in Hematologic Malignancies Detection Business of BGI Genomics (2019-2024)
Table 95. BGI Genomics Recent Developments
Table 96. Key Raw Materials Lists
Table 97. Raw Materials Key Suppliers Lists
Table 98. Hematologic Malignancies Detection Downstream Customers
Table 99. Hematologic Malignancies Detection Distributors List
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
Table 103. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Hematologic Malignancies Detection Product Picture
Figure 2. Global Hematologic Malignancies Detection Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Hematologic Malignancies Detection Sales Value (2019-2030) & (US$ Million)
Figure 4. Hematologic Malignancies Detection Report Years Considered
Figure 5. Global Hematologic Malignancies Detection Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Hematologic Malignancies Detection Revenue in 2023
Figure 7. Hematologic Malignancies Detection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Polymerase Chain Reaction Picture
Figure 9. Immunochemistry Picture
Figure 10. Next Generation Sequencing Picture
Figure 11. Fluorescence in Situ Hybridization Picture
Figure 12. Others Picture
Figure 13. Global Hematologic Malignancies Detection Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 14. Global Hematologic Malignancies Detection Sales Value Market Share by Type, 2023 & 2030
Figure 15. Product Picture of Multiple Myeloma
Figure 16. Product Picture of Myelodysplastic Syndrome
Figure 17. Product Picture of Leukemia
Figure 18. Product Picture of Myeloproliferative Neoplasms
Figure 19. Product Picture of Lymphoma
Figure 20. Product Picture of Others
Figure 21. Global Hematologic Malignancies Detection Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 22. Global Hematologic Malignancies Detection Sales Value Market Share by Application, 2023 & 2030
Figure 23. North America Hematologic Malignancies Detection Sales Value (2019-2030) & (US$ Million)
Figure 24. North America Hematologic Malignancies Detection Sales Value by Country (%), 2023 VS 2030
Figure 25. Europe Hematologic Malignancies Detection Sales Value (2019-2030) & (US$ Million)
Figure 26. Europe Hematologic Malignancies Detection Sales Value by Country (%), 2023 VS 2030
Figure 27. Asia Pacific Hematologic Malignancies Detection Sales Value (2019-2030) & (US$ Million)
Figure 28. Asia Pacific Hematologic Malignancies Detection Sales Value by Country (%), 2023 VS 2030
Figure 29. South America Hematologic Malignancies Detection Sales Value (2019-2030) & (US$ Million)
Figure 30. South America Hematologic Malignancies Detection Sales Value by Country (%), 2023 VS 2030
Figure 31. Middle East & Africa Hematologic Malignancies Detection Sales Value (2019-2030) & (US$ Million)
Figure 32. Middle East & Africa Hematologic Malignancies Detection Sales Value by Country (%), 2023 VS 2030
Figure 33. Key Countries/Regions Hematologic Malignancies Detection Sales Value (%), (2019-2030)
Figure 34. United States Hematologic Malignancies Detection Sales Value, (2019-2030) & (US$ Million)
Figure 35. United States Hematologic Malignancies Detection Sales Value by Type (%), 2023 VS 2030
Figure 36. United States Hematologic Malignancies Detection Sales Value by Application (%), 2023 VS 2030
Figure 37. Europe Hematologic Malignancies Detection Sales Value, (2019-2030) & (US$ Million)
Figure 38. Europe Hematologic Malignancies Detection Sales Value by Type (%), 2023 VS 2030
Figure 39. Europe Hematologic Malignancies Detection Sales Value by Application (%), 2023 VS 2030
Figure 40. China Hematologic Malignancies Detection Sales Value, (2019-2030) & (US$ Million)
Figure 41. China Hematologic Malignancies Detection Sales Value by Type (%), 2023 VS 2030
Figure 42. China Hematologic Malignancies Detection Sales Value by Application (%), 2023 VS 2030
Figure 43. Japan Hematologic Malignancies Detection Sales Value, (2019-2030) & (US$ Million)
Figure 44. Japan Hematologic Malignancies Detection Sales Value by Type (%), 2023 VS 2030
Figure 45. Japan Hematologic Malignancies Detection Sales Value by Application (%), 2023 VS 2030
Figure 46. South Korea Hematologic Malignancies Detection Sales Value, (2019-2030) & (US$ Million)
Figure 47. South Korea Hematologic Malignancies Detection Sales Value by Type (%), 2023 VS 2030
Figure 48. South Korea Hematologic Malignancies Detection Sales Value by Application (%), 2023 VS 2030
Figure 49. Southeast Asia Hematologic Malignancies Detection Sales Value, (2019-2030) & (US$ Million)
Figure 50. Southeast Asia Hematologic Malignancies Detection Sales Value by Type (%), 2023 VS 2030
Figure 51. Southeast Asia Hematologic Malignancies Detection Sales Value by Application (%), 2023 VS 2030
Figure 52. India Hematologic Malignancies Detection Sales Value, (2019-2030) & (US$ Million)
Figure 53. India Hematologic Malignancies Detection Sales Value by Type (%), 2023 VS 2030
Figure 54. India Hematologic Malignancies Detection Sales Value by Application (%), 2023 VS 2030
Figure 55. Hematologic Malignancies Detection Industrial Chain
Figure 56. Hematologic Malignancies Detection Manufacturing Cost Structure
Figure 57. Channels of Distribution (Direct Sales, and Distribution)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
